Joint (NASDAQ:JYNT) Stock Gets Price Target Trim from B. Riley Financial

Joint (NASDAQ:JYNT) had its price objective dropped by stock analysts at B. Riley Financial from $9.00 to $8.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. B. Riley Financial‘s price target would suggest a potential upside of 20.52% from the stock’s current price.

Several other research firms have also weighed in on JYNT. Wall Street Zen lowered Joint from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Weiss Ratings downgraded shares of Joint from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, October 26th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $8.00.

Joint Stock Performance

NASDAQ JYNT opened at $6.64 on Monday. The stock has a market capitalization of $93.86 million, a P/E ratio of 33.05 and a beta of 1.16. The business’s fifty day moving average is $7.66 and its two-hundred day moving average is $8.53. Joint has a 1 year low of $6.60 and a 1 year high of $10.67.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The business had revenue of $13.55 million during the quarter, compared to the consensus estimate of $14.85 million. Joint had a return on equity of 22.11% and a net margin of 4.81%. On average, research analysts forecast that Joint will post 0.31 earnings per share for the current year.

Institutional Trading of Joint

Several institutional investors have recently made changes to their positions in the business. R Squared Ltd boosted its holdings in Joint by 40.3% during the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock valued at $110,000 after purchasing an additional 4,284 shares in the last quarter. Strs Ohio grew its holdings in shares of Joint by 17,300.0% during the first quarter. Strs Ohio now owns 17,400 shares of the company’s stock worth $154,000 after purchasing an additional 17,300 shares during the last quarter. Grandeur Peak Global Advisors LLC acquired a new stake in shares of Joint in the second quarter valued at $19,059,000. Susquehanna International Group LLP raised its holdings in shares of Joint by 161.3% in the second quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock valued at $379,000 after buying an additional 26,626 shares during the last quarter. Finally, Squarepoint Ops LLC raised its holdings in shares of Joint by 35.5% in the second quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock valued at $926,000 after buying an additional 27,633 shares during the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

About Joint

The Joint Corp. (NASDAQ: JYNT) is a healthcare services company that operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company focuses on providing routine chiropractic care intended to support musculoskeletal health, mobility and general wellness.

The Joint Chiropractic clinics offer services such as chiropractic adjustments and related wellness care. The business model is designed to provide convenient, accessible care through walk-in visits, membership plans and prepaid packages, with an emphasis on transparent pricing and extended operating hours.